Shuyuan Mo - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Shuyuan Mo

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

The Lancet. Oncology|April 18, 2015

Nilotinib versus imatinib as first-line therapy for patients with unresectable or metastatic gastrointestinal stromal tumours (ENESTg1): a randomised phase 3 trialJean-Yves Blay, Lin Shen, Yoon-Koo Kang, et al.

Journal of Clinical and Translational Hepatology|July 5, 2021

3-year Treatment of Tenofovir Alafenamide <i>vs</i>. Tenofovir Disoproxil Fumarate for Chronic HBV Infection in ChinaJinlin Hou, Qin Ning, Zhongping Duan, et al.

Journal of Hepatology|July 25, 2020

aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitisRong Fan, George Papatheodoridis, Jian Sun, et al.

Pageof 3

Search research articles

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

The Lancet. Oncology|April 18, 2015

Journal of Clinical and Translational Hepatology|July 5, 2021

3-year Treatment of Tenofovir Alafenamide <i>vs</i>. Tenofovir Disoproxil Fumarate for Chronic HBV Infection in ChinaJinlin Hou, Qin Ning, Zhongping Duan, et al.

Journal of Hepatology|July 25, 2020

aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitisRong Fan, George Papatheodoridis, Jian Sun, et al.

Pageof 3